How many employees work at Halozyme Therapeutics?
Halozyme Therapeutics, Inc. (HALO) has approximately 514 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Halozyme Therapeutics's total headcount has declined 4.0% from 535 employees in 2023 to 514 in 2026.
Data source: Revelio LabsCoverage: Global workforce, 2023–2026Published July 2026
Is Halozyme Therapeutics hiring right now?
Yes, Halozyme Therapeutics is actively hiring. Halozyme Therapeutics had 36 active job postings in 2026, a 61.8% increase from 2025 — see job openings & hiring trends.
About Halozyme Therapeutics's Workforce
Halozyme Therapeutics, Inc. (HALO) is a Pharmaceuticals company that employs 514 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 1998, the company is headquartered in San Diego, California and trades on the NASDAQ.
Halozyme Therapeutics's workforce has declined 4.0% from 2023 to 2026, down 0.6% year over year in 2026. It reached a low of 514 in 2026 Q1 before recovering. Its workforce is concentrated most in the United States (81.0%), followed by Romania (4.2%) and India (3.8%), with Canada being its fastest-growing location.
Halozyme Therapeutics's largest functional groups are Finance and Operations (47.8%), Engineering (28.9%), and Sales and Marketing (23.3%), with Finance and Operations growing fastest (up 1.9%). The average tenure is 2.9 years, and the average salary is $151,317, ranging from a median of $148,000 in Northern America to $13,000 in Southern Asia.
Halozyme Therapeutics's active job postings rose 61.8% in 2026 to 36, with new postings per month cooling from 30 in 2023 to 11 in 2026. Overall, sentiment is neutral but improving. The company sits among its peers as the 9th-largest by headcount out of 10.
Sourced from Revelio Labs workforce data.
As of March 2026
Halozyme Therapeutics
workforce metrics
Headcount
514
0.6% YoY
Avg. Salary
$151.3k
1.3% YoY
Tenure
2.9yr
0.4yr YoY
Growth Rate
-0.6%
1.9pts YoY
Hiring Rate
Attrition Rate
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Halozyme Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
- Halozyme Therapeutics had 514 employees in 2026, a 0.6% decline (-3) from 2025.
- Halozyme Therapeutics had 523 employees in 2025, a 0.8% increase (+4) from 2024.
- Halozyme Therapeutics had 519 employees in 2024, a 3.2% decline (-16) from 2023.
- Halozyme Therapeutics had 535 employees in 2023, a 3.6% increase (+18) from 2022.
Halozyme Therapeutics's total workforce has declined from 535 employees in 2023 to 514 in 2026.
Halozyme Therapeutics, Inc. — quarterly employee count (2023–2026)
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 514 | -3 | -0.6% |
| 2025 | Q4 | 523 | +4 | +0.8% |
| 2025 | Q3 | 514 | -9 | -1.8% |
| 2025 | Q2 | 524 | +1 | +0.1% |
| 2025 | Q1 | 517 | -13 | -2.5% |
| 2024 | Q4 | 519 | -16 | -3.2% |
| 2024 | Q3 | 523 | -17 | -3.2% |
| 2024 | Q2 | 523 | -12 | -2.3% |
| 2024 | Q1 | 530 | -1 | -0.1% |
| 2023 | Q4 | 535 | +18 | +3.6% |
| 2023 | Q3 | 540 | +31 | +5.9% |
| 2023 | Q2 | 535 | +38 | +7.4% |
Want to see Halozyme Therapeutics's complete headcount history back to 2008, including quarterly breakdowns?
The United States accounts for the largest share of Halozyme Therapeutics's global workforce with approximately 81% of total employees, followed by Romania and India. Halozyme Therapeutics's headcount in Canada is growing fastest among its major locations, up 23.2% year over year in 2026.
Halozyme Therapeutics employees by country — 2026
| Country | Employees | % of Total | YoY % |
|---|---|---|---|
| United States | 412 | 81.0% | -1.5% |
| Romania | 22 | 4.2% | +3.8% |
| India | 19 | 3.8% | +0.0% |
| United Kingdom | 6 | 1.2% | +0.0% |
| Germany | 3 | 0.7% | +0.0% |
| Vietnam | 3 | 0.7% | +0.0% |
| Canada | 3 | 0.7% | +23.2% |
| Australia | 3 | 0.6% | +0.0% |
| China | 3 | 0.6% | +0.0% |
| Indonesia | 2 | 0.4% | +0.0% |
Drill into city-level data, hiring trends by region and historic geographic shifts
Halozyme Therapeutics's largest employee groups are Finance and Operations (47.8%), Engineering (28.9%), and Sales and Marketing (23.3%).
Halozyme Therapeutics employees by department — 2026
| Department | Employees | % of Total | YoY % |
|---|---|---|---|
| Finance and Operations | 241 | 47.8% | +1.9% |
| Engineering | 145 | 28.9% | -6.8% |
| Sales and Marketing | 117 | 23.3% | +0.0% |
Compare Halozyme Therapeutics's department mix to industry peers.
Halozyme Therapeutics's average employee salary is $151,317 globally. Employees in Northern America receive the highest compensation. Pay is lowest in Southern Asia, at a median of $13,000.
Halozyme Therapeutics median employee salary by region — 2026 (USD)
| Region | Median Salary |
|---|---|
| Northern America | $148,000 |
| Pacific Islands | $72,000 |
| Northern Europe | $63,000 |
| Western Europe | $47,000 |
| Eastern Europe | $30,000 |
| Eastern Asia | $30,000 |
| Arab States | $27,000 |
| Central and Western Asia | $26,000 |
| South-Eastern Asia | $20,000 |
| Southern Europe | $19,000 |
| Southern America | $18,000 |
| Southern Asia | $13,000 |
| Sub-Saharan Africa | $9,000 |
| Northern Africa | $8,000 |
Unlock salary by role, level, and city — and compare to Halozyme Therapeutics's industry peers.
- Halozyme Therapeutics had 36 active job postings in 2026, a 61.8% increase (-7) from 2025.
- Halozyme Therapeutics had 43 active job postings in 2025, a 52.9% increase (+18) from 2024.
- Halozyme Therapeutics had 25 active job postings in 2024, a 8.3% increase (+2) from 2023.
- Halozyme Therapeutics had 23 active job postings in 2023, a 60.6% decline from 2022.
- Hiring velocity in 2026: 11 new roles/month, down from 14 in 2025 and 18 in 2024. New metric
Halozyme Therapeutics's active job postings rose 61.8% in 2026 to 36, with new postings per month cooling from 30 in 2023 to 11 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Revelio Labs tracks employee sentiment across Halozyme Therapeutics's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Similar Pharmaceuticals Companies by Employee Count
- How fast is Halozyme Therapeutics growing?
- In 2026, Halozyme Therapeutics's headcount shrank 0.6% to 514 employees, down from 517 in 2025.
- Where are Halozyme Therapeutics employees located?
- Most Halozyme Therapeutics employees are based in the United States (81.0% of headcount), followed by Romania and India.
- What is the average salary at Halozyme Therapeutics?
- The average employee salary at Halozyme Therapeutics is approximately $151.3k per year.
- How many people does Halozyme Therapeutics hire per year?
- In 2026, Halozyme Therapeutics opened roughly 132 new roles — about 11 per month.
- When was Halozyme Therapeutics founded and where is it headquartered?
- Halozyme Therapeutics was founded in 1998 and is headquartered in San Diego, California.
See something that doesn't look right? Reach out and our team will review it.